Navigation Links
Life Sciences Startup PhotOral Licenses Patented Oral Blue-Light Technology From Forsyth Institute
Date:12/15/2011

BOSTON, Dec. 15, 2011 /PRNewswire/ -- Life sciences startup PhotOral™ announced today it has licensed a patented technology from Harvard-affiliated Forsyth Institute to develop a novel intraoral device that uses blue light for targeting and obliterating potentially harmful dental plaque microorganisms.

The agreement empowers newly-launched PhotOral to commercialize Forsyth's photomedicine portfolio, addressing the $7 billion oral care market. PhotOral Founder and CEO, Stamatis Astra says he's in the midst of fundraising an initial round to support prototype production, clinical trials, and marketing operations. "Our goal is to have the first intraoral light cleaning device available by late 2012," explains Astra. "We are honored to be working closely with Forsyth experts to create a portfolio of blue light therapy products, ultimately creating an evolutionary move in the oral care experience."

Forsyth Institute, the leader in oral and craniofacial research, will conduct PhotOral's clinical trials. In 2005, Drs. Nikos Soukos, DDS, PhD and Max Goodson, DDS, PhD demonstrated the susceptibility of key periodontal pathogens to blue light, suggesting the potential use of phototherapy as a targeted antimicrobial method to control growth within the dental plaque environment. The use of visible light to restore and maintain the homeostatic balance of oral microorganisms can yield microbiological, immunological and clinical benefits.

"The licensing agreement with PhotOral is a great way to get our technology out there to benefit a broad range of people," said Philip Stashenko, DMD, PhD, President and CEO of Forsyth Institute. Founding Scientists Goodson and Soukos added: "We look forward to bringing together our respective communities to open new research paths and deliver a new generation of affordable healthcare devices to the mass consumer." 

For inquiries or interviews with PhotOral Founding Scientists or CEO, please call (617) 416-4897.

About PhotOral

Boston-based PhotOralT is a life sciences startup focused on translating patented oral light technology for the consumer market with a portfolio of light therapy products and devices.

About The Forsyth Institute

Established in 1910, The Forsyth Institute in Cambridge, Massachusetts is the world's leading independent nonprofit research organization focused on oral, craniofacial and related biomedical science. Forsyth's mission is to lead the discovery, communication and application of breakthroughs in oral health and disease prevention that will significantly improve the health and well-being of the nation and the world.

Contact: @AndoniaPR:  (617) 416-4897 or via email media@photoral.com

 


'/>"/>
SOURCE PhotOral
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
2. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
3. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
4. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
5. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
6. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
7. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
8. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
9. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
10. Alfacell Corporation to Present at UBS Global Life Sciences Conference
11. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... , June 24, 2016 ... has announced the addition of the " Global ... This report ... provides an updated review, including its applications in various ... total market, which includes three main industries: pharmaceutical and ...
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, ... M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... the most handsome men, look naturally attractive. Plastic surgery should be invisible.” He ...
Breaking Medicine News(10 mins):